New Tech can help Distinguish Between Multiple System Atrophy and Parkinson’s Disease
source: pixabay.com

New Tech can help Distinguish Between Multiple System Atrophy and Parkinson’s Disease

According to a story from Medical Xpress, a new technological approach developed at the University of Texas Health Science Center at Houston will allow doctors to distinguish between Parkinson's disease…

Continue Reading New Tech can help Distinguish Between Multiple System Atrophy and Parkinson’s Disease
Experimental Treatment for Huntington’s Disease Earns Orphan Drug Designation in the EU
source: pixabay.com

Experimental Treatment for Huntington’s Disease Earns Orphan Drug Designation in the EU

According to a story from globenewswire.com, the biotechnology company Emerald Health Pharmaceuticals Inc., has announced recently that its experimental drug EHP-102 has earned Orphan Drug designation from the European Medicines…

Continue Reading Experimental Treatment for Huntington’s Disease Earns Orphan Drug Designation in the EU
Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
source: pixabay.com

Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment

FightMND is an Australian nonprofit organization dedicated to improving the lives of motor neurone disease patients through funding research for cures. They've successfully provided millions toward research initiatives and clinical…

Continue Reading Phase 2 Trial for Amyotrophic Lateral Sclerosis has Completed Enrollment
Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease
source: pixabay.com

Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease

  Falls are a symptom that affect about 60% of those with Parkinson's disease. This symptom can be debilitating, as many injuries can be the result. The University of Bristol…

Continue Reading Enrollment Open for Study of Cholinesterase Inhibitors for the Treatment of Parkinson’s Disease

New App Could Monitor Disease Progression Simply by Recording Patient’s Speech

A team of cross-disciplinary researchers at Arizona State University (ASU) is working to develop a software which patients with neurological disorders may easily use to assess their disease progression. Through…

Continue Reading New App Could Monitor Disease Progression Simply by Recording Patient’s Speech

Researchers are Gaining a Better Understanding of Disease Development at the Cellular Level

  The University of Southern California (USC) recently published an article in USC News announcing that researchers have discovered a technique allowing them to untangle the coiled, spiraling DNA molecules.…

Continue Reading Researchers are Gaining a Better Understanding of Disease Development at the Cellular Level
“I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic
source: pixabay.com

“I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic

It started with fatigue. Then came problems with moving, hand tremors and problems walking. Multiple sclerosis was ruled out by magnetic resonance imaging (MRI). But the trouble didn’t go away.…

Continue Reading “I’m 38. I Can’t Have Parkinson’s:” A Chronic Illness Story From the Czech Republic

Study Suggests That Heritable Parkinson’s Disease is More Prevalent Than Expected

According to a story from Parkinson's News Today, the results of a global, online survey appear to indicate that genetically based, inherited Parkinson's disease is actually more common than the…

Continue Reading Study Suggests That Heritable Parkinson’s Disease is More Prevalent Than Expected
Enrollment Begins for Amyotrophic Lateral Sclerosis Clinical Trial
DarkoStojanovic / Pixabay

Enrollment Begins for Amyotrophic Lateral Sclerosis Clinical Trial

According to a story from BioPortfolio, the biopharmaceutical company Collaborative Medicinal Development, LLC has recently announced that the first patient has been enrolled in a clinical trial that will test…

Continue Reading Enrollment Begins for Amyotrophic Lateral Sclerosis Clinical Trial
FDA Approves Supplementary Treatment For Parkinson’s Disease “Off” Episodes
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

FDA Approves Supplementary Treatment For Parkinson’s Disease “Off” Episodes

A recent publication from the US Food and Drug Administration announced the regulatory authority's approval of Nourianz (generic name istradefylline) for Parkinson's patients during "off" episodes. "Off" episodes are windows…

Continue Reading FDA Approves Supplementary Treatment For Parkinson’s Disease “Off” Episodes

Researchers Might Have Just Made a Breakthrough Discovery for Treating Rare Proteinopathies

It's common knowledge among researchers who study diseases called toxic proteinopathies that this group of disorders are the result of misfolded proteins that reside in cells. Certain proteins fail to…

Continue Reading Researchers Might Have Just Made a Breakthrough Discovery for Treating Rare Proteinopathies

Researchers are Working to Repair a Small Step In a Pathway Involved in Neurodegenerative Diseases

It's common knowledge among researchers who study diseases called toxic proteinopathies, that this grou of disorders are the result of misfolded proteins that reside in cells. Certain proteins fail to…

Continue Reading Researchers are Working to Repair a Small Step In a Pathway Involved in Neurodegenerative Diseases

This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station

  As reported recently in PhysOrg by NASA, researchers aboard SpaceX CRS-18 cargo flight are focusing on what triggers Parkinson’s disease and multiple sclerosis, both neurodegenerative diseases. Researchers suspect that…

Continue Reading This Time a “First-of-its-Kind” Study is “Out of this World” on Board the Space Station